New bone graft could improve foot and ankle surgery outcomes

NCT ID NCT06662266

ENROLLING_BY_INVITATION Disease control Sponsor: Red Rock Regeneration Inc. Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is testing a new bone graft material called Induce XT in 60 people undergoing foot or ankle fusion surgery. The graft is made from processed human bone and is meant to help the bones heal together. Participants will be followed for 12 months with X-rays, CT scans, and questionnaires to see how well the bone fuses and how their recovery goes.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Induce XT (a mixture of processed human cortical and cancellous bone particles)
What this could lead to: If it works, Induce XT could provide a safer, more effective bone graft option for foot and ankle fusion surgeries, reducing the need for harvesting the patient's own bone.
What could go wrong: This is an early-stage study with only 60 participants and no comparison group, so results may not be conclusive. The bone graft may not fuse as well as existing options, and there are standard surgical risks like infection or non-union.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANKLE ARTHROPATHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

arthropathy Foot Deformities

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ANKLE ARTHROPATHY FOOT DEFORMITIES SURGERY

Contacts and locations

Locations

Halifax Infirmary

Halifax, Nova Scotia, B3H A36, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.